Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Antibody Persistence and Challenge Response in Children
NCT00411697Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- May 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Dec 2006; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00411697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411697.